After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
GMED belongs to the Healthcare sector of the NYSE while operating in the Medical Devices industry. The current market capitalization of Globus Medical Inc is $10.32B. A total of 0.69 million shares were traded on the day, compared to an average of 783.50K shares.
In the most recent transaction, Davidar David D sold 30,000 shares of GMED for 75.04 per share on Oct 16 ’24. After the transaction, the Director now owns 536,275 company shares. In a previous transaction on Oct 16 ’24, Davidar David D sold 20,000 shares at 75.03 per share. GMED shares that Director owns now total 185,967.
Among the insiders who bought shares, Huller Kelly acquired of 7,500 shares on Oct 16 ’24 at a per-share price of $74.97. In another insider transaction, Davidar David D bought 3,500 shares at $74.96 per share on Oct 16 ’24.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, GMED has a high of $75.98 and a low of $43.38.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. GMED’s latest balance sheet shows that the firm has $443.45M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $29.38, while its Total Shareholder’s Equity was $1.74B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GMED is Buy with a score of 4.07.
